Ovarian cancer is the fourth-leading cause of cancer mortality among women and is characterized by late detection, extensive metastasis and poor prognosis.
Jul 19, 2023
0
61
Melanocytes are a small subset of epidermal cells that play an outsize role in protecting your skin from the damaging effects of sun exposure. They do this by synthesizing melanins, which are pigments sent to other skin cells ...
Jul 14, 2023
0
2
The overall incidence rate of pediatric cancer increased on average from 2003 to 2019, peaking in 2016, according to a study published online July 11 in the Journal of the National Cancer Institute.
Jul 13, 2023
0
0
An interdisciplinary team of researchers at the Otto-von-Guericke University in Magdeburg has gained new insights into how inflammatory mediators of pathogen defense can remotely drive cancer cells into death—an important ...
Jun 23, 2023
0
130
Loss of two key "protector" proteins initiates epigenetic changes that transform healthy lung cells into cancerous ones, according to new research from Van Andel Institute scientists.
Jun 22, 2023
0
2
The immune system protects the body from invaders, such as bacteria, viruses, or tumors, with its intricate network of proteins, cells, and organs. Specialized immune cells, called cytotoxic T cells, can develop into short-lived ...
Jun 13, 2023
0
36
Obesity has been previously linked to an increased risk of cancer, but most studies have not differentiated the risks between male and female patients. A new study published June 12 in the journal Cancer Cell takes a closer ...
Jun 12, 2023
0
87
Pandemic restrictions corresponded with a significant drop in diagnoses of breast, colorectal and prostate cancers as well as melanoma, according to a new Alberta study published in CMAJ (Canadian Medical Association Journal).
Jun 12, 2023
0
3
In a new study of trastuzumab deruxtecan, a HER2-targeted antibody drug conjugate, researchers observed encouraging responses and long-lasting clinical benefit in several tumor types. These data from an interim analysis of ...
Jun 5, 2023
0
2
Three clinical trials led by researchers at The University of Texas MD Anderson Cancer Center demonstrated positive results from the targeted therapy erdafitinib for patients with multiple tumor types harboring FGFR alterations. ...
Jun 5, 2023
0
2
